Steven Cohen Adaptive Biotechnologies Corp Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 937,331 shares of ADPT stock, worth $7.75 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
937,331
Previous 495,492
89.17%
Holding current value
$7.75 Million
Previous $2.54 Million
121.73%
% of portfolio
0.01%
Previous 0.01%
Shares
7 transactions
Others Institutions Holding ADPT
# of Institutions
225Shares Held
146MCall Options Held
19.6KPut Options Held
27.2K-
Viking Global Investors LP30MShares$248 Million0.61% of portfolio
-
Rubric Capital Management LP New York, NY14.6MShares$121 Million1.45% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$96.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.7MShares$88.6 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl9.42MShares$77.9 Million0.49% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.18B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...